Breyanzi Is Third To Market, But BMS’s First CAR-T Therapy Priced Above Competitors

Third Cell Therapy For Lymphoma Approved In The US

 
• By Mary Jo Laffler and Mandy Jackson
  
FDA - Food and Drug Administration approved text on document above stethoscope
Breyanzi was approved after an FDA delay related to manufacturing inspections • Source: Shutterstock

More from New Products

More from Scrip